References
- Minor LB, Schessel DA, Carey JP. Menière's disease. Curr Opin Neurol. 2004;17:9–16.
- Sajjadi H, Paparella MM. Menière's disease. Lancet. 2008; 372:406–14.
- Strupp M, Thurtell MJ, Shaikh AG, Brandt T, Zee DS, Leigh RJ. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol. 2011;258:1207–22.
- Lamm K, Arnold W. The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2) and auditory function in the normal and noise-damaged hypoxic and ischaemic guinea pig inner ear. Hear Res. 2000;141:199–219.
- Laurikainen E, Miller JF, Pyykko I. Betahistine effects on cochlear blood flow: from the laboratory to the clinic. Acta Otolaryngol Suppl. 2000;544:5–7.
- Dziadziola JK, Laurikainen EL, Rachel JD, Quirk WS. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg. 1999;120:400–5.
- James AL, Burton MJ. Betahistine for Menière's disease or syndrome. Cochrane Database Syst Rev. 2001;(1): CD001873.
- Strupp M, Hupert D, Frenzel C, Wagner J, Hahn A, Jahn K, . Long-term prophylactic treatment of attacks of vertigo in Menière's disease: comparison of a high with a low dosage of betahistine in an open trial. Acta Otolaryngol. 2008; 128:520–4.
- Lezius F, Adrion C, Mansmann U, Jahn K, Strupp M. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series. Eur Arch Otorhinolaryngol. 2011;268:1237–40.
- Phillips JS, Westerberg B. Intratympanic steroids for Menière's disease or syndrome. Cochrane Database Syst Rev. 2011;(7): CD008514.
- Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in Guinea pigs in vivo. PLoS One2012;7:e39086.
- Canis M, Arpornchayanon W, Messmer C, Suckfuell M, Olzowy B, Strieth S. An animal model for the analysis of cochlear blood flow (corrected) disturbance and hearing threshold in vivo. Eur Arch Otorhinolaryngol. 2010;267: 197–203.
- Gurkov R, Flatz W, Louza J, Strupp M, Ertl-Wagner B, Krause E. In vivo visualized endolymphatic hydrops and inner ear functions in patients with electrocochleographically confirmed Menière's disease.Otol Neurotol. 2012;33: 1040–5.
- Gurkov R, Flatz W, Keeser D, Strupp M, Ertl-Wagner B, Krause E. Effect of standard-dose betahistine on endolymphatic hydrops: an MRI pilot study. Eur Arch Otorhinolaryngol. 2012 (Epub ahead of print).
- Claes J, Van-de-Heyning PH. Medical treatment of Menière's disease: a review of literature. Acta Otolaryngol Suppl. 1997;526:37–42.
- James A, Thorp M. Menière's disease. Clin Evid. 2005;14: 659–65.
- Strupp M, Cnyrim C, Brandt T. Vertigo and dizziness: treatment of benign paroxysmal positioning vertigo, vestibular neuritis and Ménère's disease. In: Candelise L, editor. Evidence-based Neurology. Management of neurological disorders. Oxford: Blackwell Publishing; 2007. pp 59–69.